Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 24 November 2006:
Vol. 314. no. 5803, p. 1243
DOI: 10.1126/science.1129917

Technical Comments

Response to Comment on Suri et al. on Diabetes Reversal in NOD Mice

Anish Suri and Emil R Unanue*

Faustman et al. present no new information to explain why three independent laboratories failed to reproduce their previous results implicating spleen cell transdifferentiation in the reversal of murine type 1 diabetes. Modulation of the immunological process in nonobese diabetic (NOD) mice has been accomplished by many laboratories using different protocols and does not represent a novel finding in their work.

Department of Pathology and Immunology, Washington University School of Medicine St. Louis, MO, 63110, USA.

* To whom correspondence should be addressed. E-mail: unanue{at}pathbox.wustl.edu

Read the Full Text






To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)